JP Patent

JP5275811B2 — 少なくとも１種のレチノイド化合物と、少なくとも１種の抗刺激剤化合物とを含む組成物およびその使用

Assigned to ガルデルマ・リサーチ・アンド・デヴェロップメント · Expires 2013-08-28 · 13y expired

What this patent protects

Patent listed against Differin.

Drugs covered by this patent

Patent Metadata

Patent number
JP5275811B2
Jurisdiction
JP
Classification
—
Expires
2013-08-28
Drug substance claim
No
Drug product claim
No
Assignee
ガルデルマ・リサーチ・アンド・デヴェロップメント
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.